Pravastatin and stroke

Pravastatin may lower stroke risk in patients with coronary artery disease.

August 8, 2000

NEW YORK, August 3 (Praxis Press) The role of cholesterol-lowering therapy in reducing the risk of stroke is unknown and several epidemiological studies have concluded that there is no relation between total cholesterol levels and the risk of stroke. To study this relationship further, White and colleagues examined 9,014 patients with coronary artery disease and randomly assigned them to receive either pravastatin or a placebo. During a mean follow-up period of 6 years, 3.7% of the patients taking pravastatin had a stroke, compared with 4.5% of patients taking a placebo—a 19% reduction in the overall risk of stroke. Nonhemorrhagic stroke occurred in 3.5% of the patients taking pravastatin as compared with 4.4% of the patients taking placebo. Pravastatin has a moderate effect in reducing the risk of stroke in patients with previous myocardial infarction or unstable angina.

Popular Now

  1. Decoding the Tripping Brain
  2. Tattoo Ink Nanoparticles Persist in Lymph Nodes
    The Nutshell Tattoo Ink Nanoparticles Persist in Lymph Nodes

    Analysis of the bodies of deceased individuals can’t determine what effect these tattoo remnants have on lymph function, but researchers suggest dirty needles aren’t the only risk of the age-old practice.

  3. Do Microbes Trigger Alzheimer’s Disease?
  4. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

AAAS